Obama Kazutaka, Ura Katsuaki, Satoh Seiji, Nakamura Yusuke, Furukawa Yoichi
Laboratory of Molecular Medicine, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Oncol Rep. 2005 Sep;14(3):701-6.
To disclose molecular mechanisms of cholangiocarcinogenesis and to search for novel diagnostic markers and therapeutic targets for cholangiocarcinoma, we previously analyzed gene-expression profiles of 25 intrahepatic cholangiocarcinomas (ICCs) by means of a cDNA microarray re-presenting 27,648 genes. Among the genes frequently up-regulated in the cancer cells, we focused on PSF2 (partner of SLD five 2), a component of the GINS multiprotein complex that plays a crucial role in initiation of DNA replication. Semi-quantitative RT-PCR analysis of clinical samples confirmed high levels of PSF2 expression in the cancer cells, but expression of this gene was barely detectable in normal vital organs. Transfection of ETK-1 and HuH28 cells with short-interfering RNA specific to PSF2 reduced the amount of transcript and suppressed cell growth, suggesting that PSF2 may play an important role in development of cholangio-carcinoma. The findings reported here provide new insights into human cholangiocarcinogenesis and may contribute to the development of novel therapeutic drugs for this type of liver cancer.
为了揭示胆管癌发生的分子机制,并寻找胆管癌新的诊断标志物和治疗靶点,我们之前通过一个代表27648个基因的cDNA微阵列分析了25例肝内胆管癌(ICC)的基因表达谱。在癌细胞中频繁上调的基因中,我们聚焦于PSF2(SLD5的伙伴2),它是GINS多蛋白复合物的一个组成部分,在DNA复制起始中起关键作用。对临床样本的半定量RT-PCR分析证实癌细胞中PSF2表达水平很高,但在正常重要器官中几乎检测不到该基因的表达。用针对PSF2的短干扰RNA转染ETK-1和HuH28细胞可减少转录本数量并抑制细胞生长,这表明PSF2可能在胆管癌发生中起重要作用。此处报道的研究结果为人类胆管癌发生提供了新见解,并可能有助于开发针对这类肝癌的新型治疗药物。